載入...
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
PDE4 inhibitors can suppress a variety of inflammatory cell functions that contribute to their anti-inflammatory actions in respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma. The systemically delivered PDE4 inhibitor roflumilast has been approved for use in a subset o...
Na minha lista:
| 發表在: | Front Pharmacol |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7080983/ https://ncbi.nlm.nih.gov/pubmed/32226383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00259 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|